RSS

GE Healthcare Life Sciences

Paul Goodwin, science director, GE Healthcare Life Sciences, discusses how 3D bioprinting could advance precision health in the future. more

Opinion

GE Healthcare has teamed up with biotechnology company BeiGene to help manufacture its cancer monoclonal antibodies (mAbs). more

News

In order to boost the commercialisation of new technologies and support manufacturing capabilities in the life sciences sector, the Swedish government and GE Healthcare are opening an innovation centre — Testa Center. more

News

GE Healthcare Life Sciences has announced an increase of tenfold in its annual production capacity of powdered cell culture media at its Austrian facility. more

News

As the manufacture of biologics takes on increased significance in the pharmaceutical sector, it’s clear to see why GE Healthcare’s KUBio system is growing in popularity. Lu Rahman paid a visit to the company facility in Uppsala to find out more… more

Opinion

Biotechnology company, Clover Biopharmaceuticals, has announced its choice of biomanufacturing platform as being GE Healthcare’s FlexFactory for its new facility located in Changxing, China. more

News

GE Healthcare has announced the completion of its acquisition of a bioprocessing start-up, Puridify — which is developing a nanofiber-based platform purification technology for biopharmaceutical production. more

News

GE Healthcare has opened its first European 3D printing and design centre in Uppsala, Sweden, which will use technologies to speed up the launch of new products for healthcare. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

GE Healthcare, provider of transformational medical technologies and services, has introduced the first in its VIA Thaw series, the VIA Thaw CB1000, which offers automated, dry thawing of cryo-bags to address cell therapy challenges. more

Technology

GE Healthcare completes a strategic minority investment and fills a space in its cell therapy production with an acquisition. more

Technology

United BioPharma (UBP) has selected GE Healthcare’s FlexFactory manufacturing platform for its new facility in Taiwan. The platform will be used to build late-stage clinical and commercial production capacity for biopharmaceuticals. more

News

Collaboration jointly developed a new medium optimised for productivity of virus expression in EB66 cells. more

News

Sartorius Stedim Biotech (SSB) and GE Healthcare’s Life Sciences business (GE), have entered into a worldwide OEM supply agreement for SSB’s membrane adsorber purification technology, Sartobind more

News

GE Healthcare Life Sciences will open a technology and training lab for the fast-emerging biopharmaceutical and biotechnology industry in Turkey. more

News

In this newly-created role Olivier will oversee commercial activities in the fast-moving Asian market for GE Healthcare Life Science’s rapidly growing bioprocess business. more

Both of these developments extend Malvern’s portfolio of analytical solutions for the rapidly advancing biopharmaceutical industry. more

Xuri IL-2 is a dedicated cell therapy ancillary product for the ex vivo cultivation of T-lymphocytes. Xuri IL-2’s defined level of biological activity removes the need for revalidation of each lot and strongly improves reproducibility, thereby... more

Technology

GE Healthcare Life Sciences and JHL Biotech have announced that GE Healthcare has completed installation of its FlexFactory biomanufacturing platform at JHL Biotech’s research centre and manufacturing plant in Hsinchu, Taiwan. The new... more

Technology

Ready to use, straight from the box, ÄKTA start is a compact, affordable protein purification system. ÄKTA start represents a quick and reliable solution that removes the hassles of manual approaches and provides automated control of the purification more

Technology